Constellium SE
Constellium SE (CSTM) Financial Performance & Income Statement Overview
Analyze Constellium SE (CSTM) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Constellium SE (CSTM) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Constellium SE CSTM financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.98B | $1.92B | $1.64B | $1.79B |
| Cost of Revenue | $1.72B | $1.48B | $1.52B | $1.60B |
| Gross Profit | $263.00M | $440.45M | $114.00M | $190.00M |
| Gross Profit Ratio | $0.13 | $0.23 | $0.07 | $0.11 |
| R&D Expenses | $13.00M | $8.30M | $11.00M | $13.00M |
| SG&A Expenses | $75.00M | $87.14M | $63.00M | $77.00M |
| Operating Expenses | $166.00M | $113.44M | $70.00M | $63.00M |
| Total Costs & Expenses | $1.88B | $1.59B | $1.59B | $1.67B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $16.15M | $36.00M | $32.00M |
| Depreciation & Amortization | -$78.00M | $89.45M | $73.00M | $60.00M |
| EBITDA | -$16.00M | $92.92M | $117.00M | $192.00M |
| EBITDA Ratio | -$0.008 | $0.05 | $0.07 | $0.11 |
| Operating Income | $97.00M | $327.01M | $44.00M | $127.00M |
| Operating Income Ratio | $0.05 | $0.17 | $0.03 | $0.07 |
| Other Income/Expenses (Net) | -$35.00M | -$324.70M | -$36.00M | -$32.00M |
| Income Before Tax | $62.00M | $2.32M | $8.00M | $95.00M |
| Income Before Tax Ratio | $0.03 | $0.001 | $0.005 | $0.05 |
| Income Tax Expense | $24.00M | $35.40M | $5.00M | $24.00M |
| Net Income | $37.00M | -$34.94M | $2.00M | $71.00M |
| Net Income Ratio | $0.02 | -$0.02 | $0.001 | $0.04 |
| EPS | $0.59 | -$0.24 | $0.01 | $0.49 |
| Diluted EPS | $0.58 | -$0.23 | $0.01 | $0.48 |
| Weighted Avg Shares Outstanding | $145.49M | $145.49M | $145.49M | $146.27M |
| Weighted Avg Shares Outstanding (Diluted) | $147.44M | $147.44M | $147.44M | $149.04M |
The company's financials show resilient growth, with revenue advancing from $1.79B in Q2 2024 to $1.98B in Q1 2025. Gross profit remained healthy with margins at 13% in Q1 2025 compared to 11% in Q2 2024. Operating income hit $97.00M last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$16.00M. Net income rose to $37.00M, while earnings per share reached $0.59. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan